What is the price target for 1CORT stock?
12 analysts have analysed 1CORT.MI and the average price target is 82.87 EUR. This implies a price increase of 120.45% is expected in the next year compared to the current price of 37.59.
CORCEPT THERAPEUTICS INC (1CORT.MI) Forecast, Price Target & Analyst Ratings
BIT:1CORT • US2183521028
Current stock price
37.59 EUR
-0.43 (-1.13%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CORCEPT THERAPEUTICS INC (1CORT.MI).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Feb 18, 2026
- Period
- Q4 / 2025
- EPS Estimate
- $0.31
- Revenue Estimate
- 260.45M
Price Target Details & History
Consensus Price Target and Range
Mean target
€82.87
Upside
+ 120.45%
From current price of €37.59 to mean target of €82.87, Based on 12 analyst forecasts
Low
€43.55
Median
€87.97
High
€109.57
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
12 Wall Street analysts provided a forecast for the next 12 months for 1CORT.MI. The average price target is 82.87 EUR. This implies a price increase of 120.45% is expected in the next year compared to the current price of 37.59.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
75.00%
1CORT.MI was analyzed by 12 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about 1CORT.MI.
In the last month the buy percentage fell by 5 points. So the trust of analysts is decreasing.
1CORT.MI was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Feb 18, 2026
- Period
- Q4 / 2025
- EPS Estimate
- $0.31
- Revenue Estimate
- 260.45M
- Revenue Q2Q
- 43.19%
- EPS Q2Q
- 18.35%
- Number of Analysts
- 8
Next Earnings Revisions
Revenue (1 Month)
-13.41%
Revenue (3 Months)
-13.41%
EPS (1 Month)
-50.34%
EPS (3 Months)
-50.34%
Next Earnings Summary
1CORT.MI is expected to report earnings on 2/18/2026. The consensus EPS estimate for the next earnings is 0.31 EUR and the consensus revenue estimate is 260.45M EUR.
The next earnings revenue estimate has been revised downward by 13.41% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates 2025 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 401.9M 9.81% | 482.375M 20.02% | 675.04M 39.94% | 830.91M 23.09% | 1.077B 29.62% | 1.408B 30.73% | 2.33B 65.48% | 2.034B -12.70% | 2.351B 15.59% | 2.496B 6.17% | 2.688B 7.69% | 2.808B 4.46% | |
| EBITDA YoY % growth | 113.4M -9.71% | 108.324M -4.48% | 137.746M 27.16% | 130.13M -5.53% | 278.29M 113.86% | 450.96M 62.05% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 112.6M -9.56% | 107.282M -4.72% | 136.951M 27.66% | 95.235M -30.46% | 170.22M 78.74% | 451.48M 165.23% | 1.128B 149.84% | 1.187B 5.23% | 1.507B 26.96% | 1.739B 15.39% | 1.901B 9.32% | 2.003B 5.37% | |
| Operating Margin | 28.02% | 22.24% | 20.29% | 11.46% | 15.81% | 32.07% | 48.41% | 58.36% | 64.10% | 69.67% | 70.72% | 71.33% | |
| EPS YoY % growth | 0.88 -1.12% | 0.95 7.95% | 1.24 30.53% | 0.95 -23.36% | 0.62 -34.88% | 3.14 406.87% | 8.29 164.17% | 7.69 -7.14% | 9.72 26.29% | 10.56 8.64% | 11.48 8.74% | 12.05 4.98% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.31 18.35% | -0.09 -151.60% | 0.04 -84.52% | 0.13 -17.13% | 0.79 155.91% |
| Revenue Q2Q % growth | 260.45M 43.19% | 213.68M 35.92% | 238.21M 22.52% | 277M 33.41% | 390.22M 49.83% |
| EBITDA Q2Q % growth | 40.657M 56.03% | 55.804M 1,407.81% | 62.22M 128.36% | 85.986M 676.12% | 109.41M 169.10% |
| EBIT Q2Q % growth | 35.641M 41.09% | 6.429M 88.20% | 21.063M -21.04% | 38.046M 272.31% | 142.3M 299.26% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
36.25%
EPS Next 5 Year
44.06%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
25.84%
Revenue Next 5 Year
23.55%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
37.86%
EBIT Next 5 Year
N/A
CORCEPT THERAPEUTICS INC / 1CORT.MI Forecast FAQ
When does CORCEPT THERAPEUTICS INC (1CORT.MI) report earnings?
CORCEPT THERAPEUTICS INC (1CORT.MI) will report earnings on 2026-02-18, after the market close.
What are the consensus estimates for CORCEPT THERAPEUTICS INC (1CORT.MI) next earnings?
The consensus EPS estimate for the next earnings of CORCEPT THERAPEUTICS INC (1CORT.MI) is 0.31 EUR and the consensus revenue estimate is 260.45M EUR.
How many analysts cover CORCEPT THERAPEUTICS INC (1CORT.MI) stock?
The number of analysts covering CORCEPT THERAPEUTICS INC (1CORT.MI) is 12.